Biologically reversible phosphate and phosphonate protective gro

Details Biologically reversible phosphate and phosphonate protective gro Biologically reversible phosphate and phosphonate protective gro

1986-04-04

1989-03-28

Brown, Johnnie R.

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

536284, 536 29, C07H 1910, C07H 1920

Patent

active

048165700

ABSTRACT:
Protective groups are provided which are suitable for masking phosphates and phosphonates. The protected compositions can be introduced in a biological system and then demasked under certain biological conditions. This method permits phosphates and phosphonates which would themselves degrade in the biological system and therefore be ineffective to be introduced in a protected form and late released under the proper conditions.

REFERENCES:
patent: 3188309 (1965-06-01), Mukaiyama
patent: 3284440 (1966-11-01), Patchett
patent: 3463772 (1969-08-01), Nagyvary
patent: 3701772 (1982-10-01), Tamura
patent: 3847898 (1974-11-01), Kelly
patent: 4048307 (1977-09-01), Yokota
patent: 4056673 (1977-11-01), Heimer
patent: 4093714 (1978-06-01), Tolman
patent: 4096324 (1978-06-01), Kelly
patent: 4239905 (1980-12-01), Kodama
D. Farquhar et al, Proceedings of the 13th International Cancer Congress. Abstract 1789 (1982).
Leong, Latent Antitumor Nucleotides, 1980.
Srivastva, Organic Chemistry, presented before J.C.S. 1982, Kansas City.
Srivastva et al, Biomedical Mass Spectometry 1982.
Farquhar et al, J. of Phar. Sciences, 72, No. 3 (1983).
De Clercq, Meth. and Find. Expl. Clin. Pharmacol, 2(5), 253-267 (1980).
Indexus Chemicus, 18 No. 4, 54614 (Aug. 2, 1965).
M. MacCoss et al, 46 4th International Round Table (Antwerp, 4-6 Feb. 1981).
D. C. Remy et al, 27 Journal of Org. Chem. 27,2491-2500 (1962).
D. A. Leong, Latent Antitumor Nucleotides, 1980.
D. Farquhar, Notice of Research Report, Submitted to American Cancer Society , Inc. (Grant Application) (3-6-79).
D. N. Srivastva, Organic Chemistry, Biologically Reversible Phosphate-Protective Groups (Abstract) 1982 Presented before American Chem. Soc., Kansas City.
D. N. Srivastva et al, Biomedical Mass Spectrometry (1982) Mass Spectral Characterization of Acyloxymethyl Phosphates.
K. C. Liebman et al, 216 Journal of Biol. Chem. 823-830, (1955).
P. M. Roll et al, 220 Journal of Biol. Chem. 439-454 (1955).
E. K. Euranto et al, 20 Acta Chem. Scan. 1273-1280 (1966).
J. P. H. Verheyden et al, 35 J. Org. Chem. 2319 (1970).
P. P. Saunders et al, 30 Biochem. Pharm. 2374 (1981).
D. G. I. Kingston et al. 75 Chem. Reviews 693 (1975).
C. C. Coffin, 5 Canad. Journal Research 636 (1931).
J. A. Montgomery et al, 26 Journal of Medic. Chem. 1929 (1961).
J. A. Montgomery et al. 22 Cancer Research 504 (1962).
H. J. Thomas et al, 11 Journal Medic Chem. 44 (1968).
J. Nagyvary, 55 Biochem. and Biophys. Research Commun. 1072 (1973).
R. N. Gohil, 1 Nucleic Acids Res. 1691 (1974).
E. J. Norman, 17 Journal Medic. Chem. 473 (1974).
W. V. Daehne, 13 Journal Medic. Chem. 607 (1970).
W. J. Wheeler, 22 Journal Medic. Chem. 657 (1979).
D. Farquhar, et al, Journal of Pharmaceutical Sciences, vol. 72, No. 3 (1983).
D. Farquhar, International Congress of Chemistry, Hawaii (Dec. 1984).
Srivastva et al, Bioorganic Chemistry 12, 118-129 (1984).

Affiliated with

Also associated with

Rating

Biologically reversible phosphate and phosphonate protective gro does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biologically reversible phosphate and phosphonate protective gro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically reversible phosphate and phosphonate protective gro will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1660363